KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) EPS (Basic) (2016 - 2025)

Globus Medical's EPS (Basic) history spans 15 years, with the latest figure at $1.05 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 425.0% year-over-year to $1.05; the TTM value through Dec 2025 reached $3.98, up 423.68%, while the annual FY2025 figure was $3.98, 423.68% up from the prior year.
  • EPS (Basic) reached $1.05 in Q4 2025 per GMED's latest filing, up from $0.88 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.5 in Q2 2025 to a low of -$0.05 in Q1 2024.
  • Average EPS (Basic) over 5 years is $0.46, with a median of $0.46 recorded in 2021.
  • The largest YoY upside for EPS (Basic) was 3700.0% in 2024 against a maximum downside of 110.2% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $0.15 in 2021, then soared by 233.33% to $0.5 in 2022, then plummeted by 88.0% to $0.06 in 2023, then skyrocketed by 233.33% to $0.2 in 2024, then skyrocketed by 425.0% to $1.05 in 2025.
  • Per Business Quant, the three most recent readings for GMED's EPS (Basic) are $1.05 (Q4 2025), $0.88 (Q3 2025), and $1.5 (Q2 2025).